跳至主要内容
临床试验/NCT04546516
NCT04546516已完成不适用

Prospective Observational Clinical Trial for Safety and Efficacy of HYAcorp Lips and HYAcorp Face

BioSCIENCE GmbH2 个研究点 分布在 1 个国家目标入组 167 人开始时间: 2020年9月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
167
试验地点
2
主要终点
Wrinkle severity assessment 3 months

研究概览

简要总结

Purpose of this study is the demonstration of safety and efficacy of the dermal fillers HYAcorp Lips and HYAcorp Face for restoration of the facial volume and contour.

详细描述

This is a prospective, multicenter, observational, open label, two-arm, crossover, PMCF clinical trial for demonstration of the safety and efficacy of the HA-based dermal fillers HYAcorp Lips and HYAcorp Face for restoration of the facial volume and contour. Besides safety aspects, evaluated immediately after the treatment, 4 weeks, 3 and 6 months after the treatment, the performance of the demal fillers are evaluated in the 3 and 6 months follow-up by using GAIS and WSRS.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subjects intended for the treatment with HYAcorp Lips and/or Face according to the instructions for use of the product
  • decision for the treatment with HYAcorp Lips and/or Face was made before the subject was recruited for the clinical trial
  • subjects signed written informed consent
  • adult subjects at least 18 years old
  • all Fitzpatrick skin types
  • area treated with one investigational device - no combination of products in one treatment area

排除标准

  • tendency to hypertrophic and keloid scarring
  • intolerance to gram-positive bacteria
  • prone to active inflammatory or infectious processes
  • suffering from acute or chronic skin diseases
  • undergoing anti-coagulant therapy
  • known allergy to hyaluronic acid
  • suffering from autoimmune diseases
  • multiple allergies
  • pregnancy or lactating women
  • subjects unlikely to cooperate in the clinical investigation or to comply with the treatment or with the clinical investigation visits

结局指标

主要结局

Wrinkle severity assessment 3 months

时间窗: 3 months

Wrinkle severity assessment acc. to the Wrinkle Severity Rating Scale (WSRS); 1: wrinkles absent, 2: slight wrinkles, 3: moderate wrinkles, 4: severe wrinkles, 5: very severe wrinkles

Global aesthetic improvement 6 months

时间窗: 6 months

Global aesthetic improvement assessment acc. to the Global Aesthetic Improvement Scale (GAIS); 3: very much improved, 2: much improved, 1: improved, 0 unchanged, -1: worse

Wrinkle severity assessment 6 months

时间窗: 6 months

Wrinkle severity assessment acc. to the Wrinkle Severity Rating Scale (WSRS); 1: wrinkles absent, 2: slight wrinkles, 3: moderate wrinkles, 4: severe wrinkles, 5: very severe wrinkles

Global aesthetic improvement 3 months

时间窗: 3 months

Global aesthetic improvement assessment acc. to the Global Aesthetic Improvement Scale (GAIS); 3: very much improved, 2: much improved, 1: improved, 0 unchanged, -1: worse

Number of subjects with wrinkle severity improvement 3 months

时间窗: 3 months

Number of subjects with at least one scale point improvement in the wrinkle severity assessment (WSRS) with respect to baseline

Number of subjects with wrinkle severity improvement 6 months

时间窗: 6 months

Number of subjects with at least one scale point improvement in the wrinkle severity assessment (WSRS) with respect to baseline

次要结局

  • Product safety 6 months(6 months)
  • Product safety immediately after the treatment(Immediately after the treatment)
  • Product safety 4 weeks(4 weeks)
  • Product safety 3 months(3 months)

研究者

发起方
BioSCIENCE GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验